The nausea timeline across the first four weeks, with a tabulated log posts 91–120

Picking up post #102: that is the part I would want checked first.

Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and attenuates as the dose is held stable. At each escalation step it often resets briefly before attenuating again.

Adding it in case it saves somebody the afternoon it cost me.

Nausea timeline would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.

Distinguishing three things in the nausea timeline discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation that gets attached to both.

Coming back to post #104, because the follow-up matters more than the original answer.

The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by who chooses to post.

Building on post #106 rather than restating it.

The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of an inactive preparation.

This settles it for me, at least until somebody posts a reason it should not.

Filing a mild objection to the consensus on nausea timeline. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.

Building on post #111 rather than restating it.

What I would check first on nausea timeline is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.

Constipation is reported at least as often as nausea and is discussed a fraction as much. Fluid, fibre and movement are the boring answers and they are the ones that work.

Nausea timeline was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.

One caution on nausea timeline: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.

Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the first months when weight loss is most rapid.

That is the version I use. It may not be the version that is correct.

I read post #115 twice before replying, because I had assumed the opposite.

Nausea timeline is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.

The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of an inactive preparation.

I had written a reply contradicting post #115 and deleted it. Here is what survived.

Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some people. Site rotation, avoiding reinjection into the same area for weeks, and allowing areas that react to recover all reduce the frequency.

Useful. I had the fact and not the reason, which turns out to be the important half.